← Back to catalogue

TARGIS Targeted Transurethral Thermoablation System (TARGIS System): New Pouch Sealer

FDA PMA

Class III (US FDA PMA)

PMA P970008

by Urologix, LLC

Identity

Trade Name
TARGIS (T3) SYSTEM FDA PMA
Generic Name
System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy FDA PMA

Identifiers

PMA Number
P970008 FDA PMA
FDA Product Code
MEQ FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Gastroenterology, Urology FDA PMA
FDA Decision
APPR Approved FDA PMA

The TARGIS Targeted Transurethral Thermoablation System (TARGIS System) is a hyperthermia system using RF/microwave energy for thermotherapy in the treatment of benign prostatic hyperplasia (BPH). It is indicated to relieve symptoms associated with BPH in men with prostatic lengths between 30 and 50 millimeters.

This system is supplied as a reusable device and includes a new pouch sealer component. It received FDA PMA approval (P970008) on August 22, 1997, and is manufactured by Urologix, LLC in Plymouth, Minnesota. The device is intended for use in clinical settings under professional supervision.

Frequently asked questions

What is the TARGIS System indicated to treat?

The TARGIS System is indicated to relieve symptoms associated with benign prostatic hyperplasia (BPH) in men with prostatic lengths of 30 to 50 millimeters, as stated in the approval documentation for Model 4000.

Is the TARGIS System a single-use or reusable device?

The TARGIS System is a reusable device, as indicated by its classification and the inclusion of components like the new pouch sealer, which is part of a system designed for multiple uses under proper reprocessing.

What regulatory authorization does the TARGIS System have?

The TARGIS System has FDA Premarket Approval (PMA) under number P970008, which was granted on August 22, 1997, for the Model 4000 version of the device.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Urologix, LLC

Sources (1)

  • FDA PMA P970008 24 fields · synced Sep 18, 2026